Autoimmune polyendocrine syndrome type 1
Autoimmune polyendocrine syndrome type 1 (APS-1), is a subtype of autoimmune polyendocrine syndrome (autoimmune polyglandular syndrome) in which multiple endocrine glands dysfunction as a result of autoimmunity. It is a genetic disorder inherited in autosomal recessive fashion due to a defect in the AIRE gene (autoimmune regulator), which is located on chromosome 21 and normally confers immune tolerance.[4][6][7]
Autoimmune polyendocrine syndrome type 1 | |
---|---|
Other names | Autoimmune polyendocrinopathy-candidiasis–ectodermal dystrophy/dysplasia (APECED), Autoimmune polyglandular syndrome type 1, Whitaker syndrome,[1] or Candidiasis-hypoparathyroidism–Addison's disease syndrome,[2] |
Autoimmune polyendocrine syndrome type 1 is autosomal recessive | |
Specialty | Endocrinology |
Symptoms | Chronic Mucocutaneous Candidiasis[3] |
Causes | Defect in AIRE gene[4] |
Diagnostic method | CT scan, Histologic test[1] |
Treatment | Hormone replacement[5] |
Signs and symptoms
Autoimmune polyendocrine syndrome type 1 symptoms and signs include the following:[3]
- Chronic Mucocutaneous Candidiasis
- Hypoparathyroidism
- Autoimmune Adrenal Insufficiency
- Ectodermal Dystrophy (skin, dental enamel, and nails)
Additional manifestations include
Genetics
Autoimmune polyendocrine syndrome type 1 is a condition caused in an autosomal recessive manner. Furthermore, it is due to a defect in AIRE gene (which helps to make a protein that is called the autoimmune regulator) mapped to 21q22.3 chromosome location, hence chromosome 21.[4][6][8]
Pathophysiology
In autoimmune polyendocrine syndrome type 1 mechanism one finds that the maintenance of immunological tolerance plays a role.[9] Furthermore, upon looking at the AIRE gene, one finds at least 90 mutations in the gene, in those affected with this condition.
Autoimmune polyendocrine syndrome type 1 mechanism also indicates that affected individuals autoantibodies have considerable reactions with both interferon-omega and interferon alpha.[1]
Diagnosis
In terms of diagnosis for this condition, the following methods/tests are available:[1]
- Endoscopic
- CT scan
- Serum endocrine autoantibody screen
- Histologic test
Treatment
Autoimmune polyendocrine syndrome type 1 treatment is based on the symptoms that are presented by the affected individual, additionally there is:[5]
- Hormone replacement
- Systemic antifungal treatment
- Immunosuppressive treatment
References
- "Polyglandular Autoimmune Syndrome, Type I - eMedicine Endocrinology". Medscape. Retrieved 2009-04-17.
- Greenspan, Francis S.; Gardner, David C. (2004). Basic clinical endocrinology. New York: McGraw-Hill. pp. 103. ISBN 978-0-07-140297-2.
- "Autoimmune polyglandular syndrome type 1 | Genetic and Rare Diseases Information Center (GARD) – an NCATS Program". rarediseases.info.nih.gov. Retrieved 2017-04-11.
- Reference, Genetics Home. "AIRE gene". Genetics Home Reference. Retrieved 2017-04-04.
- RESERVED, INSERM US14 -- ALL RIGHTS. "Orphanet: Autoimmune polyendocrinopathy type 1". www.orpha.net. Retrieved 2017-04-22.
- Reference, Genetics Home. "APECED". Genetics Home Reference. Retrieved 2017-04-04.
- Shoenfeld, Yehuda; Cervera, Ricard; Gershwin, M. Eric (2010-06-08). Diagnostic Criteria in Autoimmune Diseases. Springer Science & Business Media. p. 265. ISBN 9781603272858.
- "Autoimmune Polyglandular Syndrome Type 1 (APS-1) | NIH: National Institute of Allergy and Infectious Diseases". www.niaid.nih.gov. Retrieved 2017-04-16.
- De Martino, Lucia; Capalbo, Donatella; Improda, Nicola; D’Elia, Federica; Di Mase, Raffaella; D’Assante, Roberta; D’Acunzo, Ida; Pignata, Claudio; Salerno, Mariacarolina (2013-10-23). "APECED: A Paradigm of Complex Interactions between Genetic Background and Susceptibility Factors". Frontiers in Immunology. 4: 331. doi:10.3389/fimmu.2013.00331. ISSN 1664-3224. PMC 3805967. PMID 24167503.
Further reading
- De Martino, Lucia; Capalbo, Donatella; Improda, Nicola; Lorello, Paola; Ungaro, Carla; Di Mase, Raffaella; Cirillo, Emilia; Pignata, Claudio; Salerno, Mariacarolina (1 January 2016). "Novel Findings into AIRE Genetics and Functioning: Clinical Implications". Frontiers in Pediatrics. 4: 86. doi:10.3389/fped.2016.00086. PMC 4992815. PMID 27597936.
- Peterson, P; Pitakanen, J; Sillanpaa, N; Krohn, K (2004). "Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED): a model disease to study molecular aspects of endocrine autoimmunity". Clinical and Experimental Immunology. 135 (3): 348–357. doi:10.1111/j.1365-2249.2004.02384.x. PMC 1808970. PMID 15008965.
- Capalbo, Donatella; De Martino, Lucia; Giardino, Giuliana; Di Mase, Raffaella; Di Donato, Iolanda; Parenti, Giancarlo; Vajro, Pietro; Pignata, Claudio; Salerno, Mariacarolina (2012). "Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy: Insights into Genotype-Phenotype Correlation". International Journal of Endocrinology. 2012: 1–9. doi:10.1155/2012/353250. PMC 3485503. PMID 23133448.
External links
Classification | |
---|---|
External resources |